Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 18
Review
A Health Technology Assessment Based on Chinese Guidelines: Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Type 2 Diabetes Complicated with Cardiovascular Disease
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,252 | Dovepress* | 3,830+ | 243 | 4,073 | |
| PubMed Central* | 422 | 142 | 564 | ||
| Totals | 4,252 | 385 | 4,637 | ||
| *Since 30 August 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar